Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04606199 · ClinicalTrials.gov registry record · NA

Examine the Effects of Meditation on Daily Psychological Stress Responses in Woman With a History of Child Adversity

A NA study of Stress and Depressive Symptoms, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT04606199: Completed NA study of Stress and Depressive Symptoms, sponsored by University of California, San Francisco.

NCT04606199 is a NA study of Stress and Depressive Symptoms that has completed, run by University of California, San Francisco. The registered enrollment target is 53 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04606199, a NA study of Stress and Depressive Symptoms, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The aim of the Everyday Moments of Mindfulness (EMMI) study is to test whether brief mindfulness-based practices will improve daily psychological stress responses in women (age 30-60) who report a history of early life adversity. Following a baseline visit (remotely or in person), participants complete daily surveys and audio-guided mindfulness-based practices in everyday life via the study app. Specifically, participants receive app-notifications three times/day (morning, afternoon, evening) to complete daily surveys of current stressors and psychological states. At each notification, each participant is then randomly assigned to either receive a mindfulness-based intervention or not (max of 3 interventions/day). Thus, participants are randomized many times over the course of this 30-day study. At the end of the study, participants complete a follow-up visit (remotely or in person).

Primary Outcome

Stressor demands were measured by computing a total mean score of "I feel stressed, anxious, overwhelmed" and "I feel strained, upset, overburdened." The total mean score ranges from 1 to 7, with higher scores indicating greater stressor demands. Stressor demands were assessed at notification time points 3 times/day over a 30-day period. At each notification time point, participants completed EMAs of stressor demands immediately prior to intervention randomization (pre-EMA) and approximately 15

Interventions

  • BEHAVIORAL Mindfulness-based intervention, up to 5 minutes 0-3 times/day

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2020-11-02
Est. Completion 2021-07-12
Phase NA

What the finished NCT04606199 record still lists

NCT04606199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (93% lower).

The record links to 7 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-based intervention, up to 5 minutes 0-3 times/day is the first listed.

NCT04606199 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04606199 about?

NCT04606199 is a clinical study titled "Examine the Effects of Meditation on Daily Psychological Stress Responses in Woman With a History of Child Adversity". The aim of the Everyday Moments of Mindfulness (EMMI) study is to test whether brief mindfulness-based practices will improve daily psychological stress responses in women (age 30-60) who report a history of early life adversity. Following a baseline visit (remotely or in person), participants compl...

What is the current status of trial NCT04606199?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2020-11-02. Estimated completion is 2021-07-12.

What conditions does trial NCT04606199 study?

This clinical trial studies the following conditions: Stress, Depressive Symptoms, Psychological Distress, Child Maltreatment, Psychological Stress.

What interventions are being tested in trial NCT04606199?

The interventions under investigation include: Mindfulness-based intervention, up to 5 minutes 0-3 times/day (BEHAVIORAL).

Who is sponsoring clinical trial NCT04606199?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04606199 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04606199's enrollment target sits among peer trials

53 99th of 152 higher than 50 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04606199, the US trial registry maintained by the National Library of Medicine. NCT04606199 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.